This website is intended for healthcare professionals only.

Newsletter          
Hospital Healthcare Europe
HOPE LOGO
Hospital Healthcare Europe

*** Editor’s Pick

Increased physical activity lowers hospitalisation risk for wide range of health conditions
Increased physical activity lowers hospitalisation risk for wide range of health conditions
Intranasal epinephrine provides comparable outcomes to IM auto-injector
Intranasal epinephrine provides comparable outcomes to IM auto-injector
Dupilumab treatment improves spontaneous chronic urticaria activity and quality of life
Dupilumab treatment improves spontaneous chronic urticaria activity and quality of life
A coffee intake change from low to moderate reduces total body fat in metabolic syndrome
A coffee intake change from low to moderate reduces total body fat in metabolic syndrome
Rucaparib offers survival advantage over usual care in metastatic prostate cancer
Rucaparib offers survival advantage over usual care in metastatic prostate cancer
Aspirin use benefits reduced by statins in those without atherosclerotic disease
Aspirin use benefits reduced by statins in those without atherosclerotic disease
Increased NT-proBNP levels over time linked to greater risk of heart failure and death
Increased NT-proBNP levels over time linked to greater risk of heart failure and death
Decongestant medicines under review by regulators after rare side effects
Decongestant medicines under review by regulators after rare side effects
NICE rejects rimegepant for acute migraine treatment
NICE rejects rimegepant for acute migraine treatment
Automated dispensing systems for the safe management of controlled drugs
Automated dispensing systems for the safe management of controlled drugs
Adherence to NICE criteria for biologic treatment in atopic dermatitis
Adherence to NICE criteria for biologic treatment in atopic dermatitis
Syfovre approved for geographic atrophy in advanced age-related macular degeneration
Syfovre approved for geographic atrophy in advanced age-related macular degeneration


Popular articles

Shorter tuberculosis treatment strategy non-inferior to standard regimen
Prostate cancer mortality no different in trial of three treatment interventions
High-sensitivity CRP superior to LDL cholesterol for CV event and mortality risk prediction
Ide-cel provides 51% reduction in the risk of progression or death in R/R multiple myeloma
Higher plasma caffeine levels linked to reduced body fat and type 2 diabetes risk according to genetic study




 

Download Hospital Healthcare Europe free app

Download our app from the Apple App Store Download our app from Google Play

In official association with

HOPE Logo Footer

© Cogora 2023
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora